Clinical Trial Results:
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects with Active Rheumatoid Arthritis Despite Methotrexate Therapy
Summary
|
|
EudraCT number |
2008-006064-11 |
Trial protocol |
LT HU |
Global completion date |
08 Feb 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Nov 2016
|
First version publication date |
06 Nov 2016
|
Other versions |
|
Summary report(s) |
CNTO148ART3001_2008-006064-11_(golimumab)_24Week_CSR Synopsis CNTO148ART3001_2008-006064-11_(golimumab)_52Week_CSR Synopsis CNTO148ART3001_2008-006064-11_(golimumab)_112 Week_CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.